![](/assets/icon.png)
1. The cumulative rate of isolated pelvic metastasis and incidental pelvic tumors in patients receiving treatment for hepatocellular carcinoma (HCC) was 4.0% and 5.3%, respectively, after one year.
2. Baseline T stage was associated with an increased risk of isolated pelvic metastasis (P=.01).
3. Pelvic coverage increased the radiation dose by 29-39% when compared to non-enhanced liver CT scans.
The article is generally reliable and trustworthy, as it provides a comprehensive overview of the added value of pelvic coverage with follow-up liver CT scans in patients treated for HCC without extrahepatic metastasis at initial diagnosis. The article is well-structured and provides a clear explanation of the study design, patient selection criteria, imaging acquisition methods, and outcome assessment process. The authors also provide a detailed discussion on the potential benefits and risks associated with increasing the coverage of CT scans in this population.
However, there are some potential biases that should be noted in this article. First, the study is retrospective in nature, which may limit its generalizability to other populations or settings due to selection bias or confounding factors that were not accounted for in the analysis. Second, the sample size was relatively small (n = 478), which may have limited the power of the study to detect significant differences between groups or outcomes. Third, although the authors discuss potential benefits and risks associated with increasing coverage of CT scans, they do not provide any evidence to support their claims or explore possible counterarguments that could be made against their conclusions. Finally, there is no mention of any promotional content or partiality in this article; however, it should be noted that this study was conducted at a single institution and may not reflect results from other institutions or settings.